These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2133215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD, Morrice JJ, Forbes CD, Prentice CR, Fulton AJ, Barbenel JC.
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [Abstract] [Full Text] [Related]

  • 3. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
    Bell WR, Shapiro SS, Martinez J, Nossel HL.
    J Lab Clin Med; 1978 Apr; 91(4):592-604. PubMed ID: 641385
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
    Prentice CR, Hampton KK, Grant PJ, Nelson SR, Nieuwenhuizen W, Gaffney PJ.
    Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of severe intermittent claudication by controlled defibrination.
    Dormandy JA, Goyle KB, Reid HL.
    Lancet; 1977 Mar 19; 1(8012):625-6. PubMed ID: 66429
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ancrod.
    Sherman DG.
    Curr Med Res Opin; 2002 Mar 19; 18 Suppl 2():s48-52. PubMed ID: 12365829
    [Abstract] [Full Text] [Related]

  • 13. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S, Wadhwa NK, Kant KS, Pollak VE, Glas-Greenwalt P, Weiss MA, Hong CG.
    Q J Med; 1988 Nov 19; 69(259):879-905. PubMed ID: 3078212
    [Abstract] [Full Text] [Related]

  • 14. Beta blockade and intermittent claudication.
    Lepäntalo M.
    Acta Med Scand Suppl; 1985 Nov 19; 700():1-48. PubMed ID: 2865873
    [Abstract] [Full Text] [Related]

  • 15. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease.
    Vigilance JE, Reid HL.
    J Diabetes Complications; 2008 Nov 19; 22(3):210-6. PubMed ID: 18413225
    [Abstract] [Full Text] [Related]

  • 16. Defibrinogenating enzymes.
    Bell WR.
    Drugs; 1997 Nov 19; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [Abstract] [Full Text] [Related]

  • 17. Studies on haematocrit in peripheral arterial disease.
    Lowe GD, Saniabadi A, Turner A, Lieberman P, Pollock J, Drury J.
    Klin Wochenschr; 1986 Oct 01; 64(19):969-74. PubMed ID: 3784449
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.
    Glas-Greenwalt P, Kant KS, Dosekun A, Frazier J, Allen C, Pollak VE.
    J Lab Clin Med; 1985 Jan 01; 105(1):99-107. PubMed ID: 3871465
    [Abstract] [Full Text] [Related]

  • 20. Peripheral sympathetic autoregulation in arterial calf inflow enhancement with intermittent pneumatic compression.
    Delis KT, Nicolaides AN, Wolfe JH.
    Eur J Vasc Endovasc Surg; 2001 Oct 01; 22(4):317-25. PubMed ID: 11563890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.